Skip to main content
. 2008 Oct 16;75(1):218–226. doi: 10.1124/mol.108.051110

Fig. 8.

Fig. 8.

Effect of the prolyl oligopeptidase inhibitor BCPP on metabolism of [3H]tasidotin by CCRF-CEM leukemia cells. Cells were incubated for 18 h with 20 μM [3H]tasidotin without (A) or with (B) 12.5 μM BCPP, and soluble radiolabel was evaluated by HPLC and flow detector analysis.